Ninety One North America’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-15,641
Closed -$755K 119
2016
Q3
$755K Hold
15,641
0.1% 114
2016
Q2
$867K Buy
15,641
+2,200
+16% +$121K 0.13% 105
2016
Q1
$718K Buy
13,441
+3,849
+40% +$190K 0.12% 106
2015
Q4
$494K Hold
9,592
0.09% 104
2015
Q3
$433K Buy
9,592
+258
+3% +$12.2K 0.11% 104
2015
Q2
$432K Hold
9,334
0.14% 90
2015
Q1
$400K Buy
+9,334
New +$356K 0.12% 90

Other funds holding PBH

Ninety One North America's PBH Position: Q4 2016 in Review

Ninety One North America sold out of Prestige Consumer Healthcare (PBH) in Q4 2016, closing a stake of 15,641 shares — an estimated $755K sold.

Ninety One North America first reported a position in PBH in Q1 2015 and held it in 7 quarters. The position peaked at $867K in Q2 2016. 238 funds tracked by Wall St. Rank hold PBH as of Q4 2016.

  • Ninety One North America reported no remaining Prestige Consumer Healthcare position as of Q4 2016 after selling out during the quarter.
  • Ninety One North America sold 15,641 Prestige Consumer Healthcare shares in Q4 2016, an estimated $755K.
  • Ninety One North America first reported a position in Prestige Consumer Healthcare in Q1 2015 and held it in 7 quarters.
  • Ninety One North America's Prestige Consumer Healthcare position peaked at $867K in Q2 2016.
  • 238 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2016.

Based on Ninety One North America's 13F filing for Q4 2016, filed 10 Feb 2017.